Mother-Son Duo Offer Biopharma KOL Mapping with Adnexi CEO Sandra Shpilberg
![Biopharma KOL Mapping](https://vibebio.com/wp-content/uploads/2024/06/Biopharma-KOL-Mapping-1024x171.png)
Sandra Shpilberg, Co-founder and CEO of Adnexi, discusses using AI to develop effective strategies for biopharma key expert and digital opinion leader selection to elevate your product launch.
Developing a Small Molecule for Duchenne Muscular Dystrophy with Frank Gleeson | VibeCast Episode 48
![Developing a Small Molecule for Duchenne Muscular Dystrophy](https://vibebio.com/wp-content/uploads/2024/03/Developing-a-Small-Molecule-for-Duchenne-Muscular-Dystrophy-1024x171.png)
Frank Gleeson, Co-Founder and CEO of Satellos Bioscience, discusses groundbreaking small molecule therapies for Duchenne muscular dystrophy.
The Impact Review – Founding Vibe Bio
![The Impact Review – Founding Vibe Bio](https://vibebio.com/wp-content/uploads/2023/09/the_impact_review_cover-1024x171.jpg)
The Impact Review article explores Alok Tayi’s personal experience with rare disease drove him towards a mission – to fund cures for rare diseases.
The Biotech Startups Podcast with guest Alok Tayi, Founder & CEO of Vibe Bio
![The Biotech Startups Podcast with guest Alok Tayi, Founder & CEO of Vibe Bio](https://vibebio.com/wp-content/uploads/2023/08/BioTechStartupsPodcast-1024x171.png)
Learn how Vibe Bio is tackling the problem of funding & guiding high potential drug programs.
Forbes – Alok Tayi’s new start-up is putting drug development into patients’ hands
![Select Forbes – Alok Tayi’s new start-up is putting drug development into patients’ hands Forbes – Alok Tayi’s new start-up is putting drug development into patients’ hands](https://vibebio.com/wp-content/uploads/2023/05/drugdevpatientshands-1024x171.png)
This article examines how Vibe Bio’s Founder and CEO is putting drug development into patients’ hands.